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Abstract 
N-(benzothiazol-2-yl)-2-nitrobenzenesulphonamide (NBS2ABT) was synthesized by the condensation of 2-
aminobenzothiazole and 2-nitrobenzenesulphonylchloride under reflux. Five metal complexes of Cu(I), Ni(II), 
Mn(II), Co(II) and Zn(II) of the ligands were synthesized. The compounds were characterized using magnetic 
susceptibility measurements, mass spectrometry, elemental microanalysis, UV/VIS spectrophotometry, infra red, 
1H and 13C nmr spectroscopies. The antimicrobial tests of the ligands and its metal complexes were carried out 
on both multi-resistant bacterial strains isolated under clinical conditions and cultured species using agar-well 
diffusion method. The multi-resistant bacterial strains used were E. coli, Proteus species, P. aeroginosa and S. 
aureus which were isolated from dogs. The culture species were P. aeruginosa (ATCC 27853), E. coli (ATCC 
25922), S. aureus (ATCC 25923), and the fungi, C. krusei (ATCC 6258) and C. albicans (ATCC 90028). The 
tests were both in vitro and in vivo. The antimicrobial activities of the compounds were compared with those of 
Ciprofloxacin and trimethoprim-sulphamethoxazole as antibacterial agents and Fluconazole as an antifungal 
drug. All the compounds showed varying activities against the cultured typed bacteria and fungi used. The 
Lethal Concentration (LC50) ranged from 5.00±0.86-618.90±30.8 ppm. These are within the permissible 
concentrations. 
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1. INTRODUCTION  
This is part of the series of work we have done on syntheses of thiazole derivatives and their metal 
complexes. Literatures have shown that thiazoles have antituberculous, antibacterial, antifungal 
properties(1-5). The success of sulfapyridine in combating bacterial infections, particularly pneumococcal 
infections has led to the preparation and study of other heterocyclic derivatives of sulfonamide(6). Mixed 
ligand complexes of Mn(II), Co(II), Ni(II), Cu(II) and Zn(II) derived from 1,10–phenanthroline and o-
vanillidene-2-aminobenzothiazole, and Schiff base metal complexes of o-vanillidene-2-amino-N-(2-
pyridyl)-benzene sulfonamide  have been studied. The metal complexes show more potent activities 
compared with Schiff base ligands(7). It is known that metal chelates of ligands with sulphur or nitrogen 
donor atoms have interesting physicochemical properties as well as physiological activities(8-9). In an era 
of decreasing microbial susceptibilities to current available antimicrobials, there is a pressing need to 
develop new agents and therapeutic strategies for the treatment of infectious diseases(10). 
This work is aimed at synthesizing N-(benzothiazol-2-yl)-2-nitrobenzenesulphonamide and its Cu(I), Ni(II), 
Mn(II), Co(II) and Zn(II) complexes, characterizing them, and investigating how their structural differences 
affects antimicrobial activities when compared with conventional sulfonamides. 
 
2. EXPERIMENTAL  
2.1 Reagents and apparatus 
The ligand, N-(benzothiazol-2-yl)-2-nitrobenzenesulphonamide (NBS2ABT) and the metal complexes were 
prepared based on the procedure earlier reported by Obasi et al.(11). All reagents were of analytical grade and 
were used as supplied except otherwise stated. UV-Visible spectra were obtained on UV-2550 UV-VIS 
Spectrophotometer, (SHIMADZU). FTIR spectra run as Nujol mulls on FTIR-84005 FTIR Spectrophotometer, 
(SHIMADZU). 13C and 1H NMR spectra were recorded on Bruker-BioSpin 500 MHz NMR Spectrometer (UK) 
using DMSO and CDCl3 as solvents respectively. The proton NMR peaks were observed at 400 MHz whereas 
the carbon-13 spectra were observed at about 200 MHz. Elemental analysis was done using LECO-CHNS 932 
microanalysis apparatus, the mass spectrometric analysis was done using Thermo Finnigan LCQ DUO machine 
by electrospray ion trap method, and the magnetic susceptibility of the complexes were determined using 
Sherwood Scientific Magnetic Susceptibility Balance, Mk1 Model (Cambridge, UK), all at the Department of 
Pure and Applied Chemistry, University of Strathclyde, Scotland, UK. 
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2.2 Synthesis of N-(benzothiazol-2-yl)-2-nitrobenzenesulphonamide(NBS2ABT) 
The procedure for the synthesis was as reported by Obasi et al.(11). A yellow precipitate was formed and was 
recrystallised in absolute ethanol.  UV (λmax nm) (DMSO), (ε):195.2, (1.15 ×103), 370.0 (6.10×104); IR (υ cm-1): 
3450 (br), 2853(s), 2734 (sh), 1655(sh) 1627 (sh), 1543 (s), 1461 (s), 1378 (s), 1217 (m), 846 (w), 746 (m), 645 
(w);  1H NMR (δppm): 7.51(4H, m), 8.12 (4H,m), 9.62 (1H,s); 13C NMR (δppm): 168.4, 147.9, 136.8, 134.7, 
134.5, 133.0, 129.8, 128.1, 125.7, 124.9, 123.6, 113.9. 
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Scheme 1: Synthesis of NBS2ABT 
 
2.3 Synthesis of Bis[N-(benzothiazol-2-yl)-2-nitrobenzenesulphonamide] nickel(I) chloride (Ni(I)NBS2ABT) 
 
The procedure for the synthesis was as reported by Obasi et al.(11). A light yellow needle-like solid was formed. 
This was filtered and dried in a stream of air and stored in desicator. UV (λmax nm) (DMSO), (ε):364.5 (27 440 
cm-1), (24.1 ×103), 371.0 (26 950 cm-1) (181×104), 734.5(13 620 cm-1) (18.2×105); IR (υ cm-1): 3430 (br), 2924 
(s), 2854 (s), 1601 (s), 1534 (s), 1459 (s), 1380 (s),  1333 (s), 1246 (s), 958 (s),  837 (s), 685 (s) , 663 (w), 345 
(s), 350 (s); 13C NMR (δppm): 167.3, 136.5, 127.6, 125.4, 124.0, 113.1. 
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Scheme 2: Synthesis of Ni(I)NBS2ABT 
2.4 Synthesis of Bis[N-(benzothiazol-2-yl)-2-nitrobenzenesulphonamide]dichloromanganese(II) 
(Mn(II)NBS2ABT) 
 
The procedure for the synthesis was as reported by Obasi et al.(11). A yellow needle-like solid was formed. This 
was filtered and dried in a stream of air and stored in desicator. UV (λmax nm) (DMSO), (ε):321.5 (31 100 cm-1), 
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(18.5×103), 328.5 (30 440 cm-1) (189×104), 734.0 (13 620 cm-1) (18.7×105); IR (υ cm-1): 3410 (br), 2954 (s), 
2854 (s), 1605 (s), 1545 (s), 1462 (s), 1335 (s), 1254 (s), 955 (s), 836 (s), 683 (s), 587 (w), 395 (s), 360 (s); 13C 
NMR (δppm): 170.1, 147.7, 139.4, 134.7, 134.6, 127.9, 124.8, 124.4, 123.3, 113.9. 
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Scheme 3: Synthesis of Mn(II)NBS2ABT 
 
2.5 Synthesis of Bis[N-(benzothiazol-2-yl)-2-nitrobenzenesulphonamide]dichlorocobalt(II) (Co(II)NBS2ABT) 
 
The procedure for the synthesis was as reported by Obasi et al.(11). A light blue needle-like solid was formed. 
This was filtered and dried in a stream of air and stored in desicator. UV (λmax nm) (DMSO), (ε):321.5 (31 100 
cm-1), (186×103), 328.5 (30 440 cm-1) (19.0×104), 734.0 (13 620 cm-1) (18.8×105); IR (υ cm-1): 3430 (br), 2923 
(s), 2854 (s), 1601 (s), 1534 (s), 1465 (s), 1380 (s), 1334 (s), 1246 (s), 958 (s), 837 (s), 663 (s), 581 (w), 392 (s), 
350 (s); 13C NMR (δppm): 168.3, 147.7, 136.7, 134.5, 134.4, 132.9, 129.6, 128.0, 125.6, 124.8, 123.4, 113.8. 
 
2.6 Synthesis of Bis[N-(benzothiazol-2-yl)-2-nitrobenzenesulphonamide]zinc(II) chloride (Zn(II)NBS2ABT) 
 
The procedure for the synthesis was as reported by Obasi et al.(11). A light yellow crystalline solid was formed. 
This was filtered and dried in a stream of air and stored in desicator. UV (λmax nm) (DMSO), (ε):340.0 (29 410 
cm-1), (14.7×103), 344.0 (29 060  cm-1) (147×104), 348.5 (28 700 cm-1) (1450×105); IR (υ cm-1): 3362 (br), 2924 
(s), 2854 (s), 1610 (s), 1540 (s), 1466 (s), 1374 (s) , 1310 (s), 1275 (w), 947 (s), 836 (s), 684 (s),  615 (w), 345 
(s), 355 (s); 1H NMR (δppm): 7.41(4H, m), 7.85(2H,d), 7.93(2H,d), 13.43(1H,s); 13C NMR (δppm): 168.3, 
147.7, 136.9, 134.5, 134.4, 132.9, 130.0, 129.7, 125.7, 124.8, 123.4, 113.9. 
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Scheme 4: Synthesis of Co(II)NBS2ABT 
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Scheme 5: Synthesis of Zn(II)NBS2ABT 
 
2.7 Synthesis of Bis[N-(benzothiazol-2-yl)-2-nitrobenzenesulphonamide] copper(I) chloride (Cu(I)NBS2ABT) 
 
The procedure for the synthesis was as reported by Obasi et al.(11). A brownish powdery solid was formed. This 
was filtered and dried in a stream of air and stored in desicator. UV (λmax nm) (DMSO), (ε):340.0 (29 410 cm-1), 
(14.7×103), 344.0 (29 000  cm-1) (146×104); IR (υ cm-1): 3400 (br), 2924 (s), 2854 (s), 1601 (s), 1534 (s), 1465 
(s), 1380 (s), 1334 (s), 1256 (s), 957 (s), 837 (s), 663 (s), 350 (s), 325 (s); 1H NMR (δppm): 7.44(4H, d), 
8.15(2H,d), 13.56(1H,s); 13C NMR (δppm): 168.3, 147.7, 136.9, 134.5, 134.4, 132.9, 129.7, 128.0, 125.7, 
124.8, 123.4, 113.9. 
 
Chemistry and Materials Research                                                                                                                                                    www.iiste.org 
ISSN 2224- 3224 (Print) ISSN 2225- 0956 (Online) 
Vol.6 No.3, 2014 
 
120 
N-(benzothiazol-2-yl)-2-nitrobenzenesulfonamide
+
N
S
NH
S
O
O
NO 2
Bis [N-(benzothiazol-2-yl)-2-nitrobenzenesulphonamide]copper(I) chloride
N
S
NH
S
O
O
NO 2
N
S
NH
S
O
O
O 2N
2
120 癈DMF
CuCl 2.2H 2O
Cu Cl
-
+ 
 
Scheme 6: Synthesis of Cu(I)NBS2ABT 
 
2.8 Antimicrobial properties 
2.8.1In vitro Tests 
Multi-resistant bacterial strains isolated under clinical conditions and Typed strains (ATCC Cultures) were used 
in the study. The bacterial strains used were as reported in our earlier publications(11). The Typed strains were 
obtained from Bioresources Development and Conservation Program (BDCP), International Centre for 
Ethnomedicine and Drug Development (IntaceEED), Nsukka, Nigeria. 
The antibacterial and antifungal activities of the ligand, NBS2ABT, and its complexes against these multi-
resistant bacteria were determined using the agar well diffusion method as described by Chah et al(12).  
The minimum inhibitory concentrations (MICs) of the test compounds were determined using the agar dilution 
method as described by Ojo et al(13).  
 
2.8.2 In vivo Tests [Brine Shrimps Lethality Test (BSLT)] 
The method of McLaughlin and coworkers was used to study the bioactivity of the synthesized compounds(14). 
Artemia salina eggs obtained from a pet shop in Davis California was incubated in natural sea water (from Bar 
Beach, Lagos, Nigeria) in a dam-well under room condition. The results were analysed using Finney Probit 
Analysis (MS-DOS-Computer-Program) to determine the LC50 at 95% confidence interval. Weak nauplii were 
noted as an indication of central nervous system depression.    
3 RESULTS AND DISCUSSION 
4 Physical Properties of the Compounds and  Elemental microanalysis of the ligand 
Table 1 shows some physical properties of both ligand and its complexes. The result of the elemental 
microanalysis is recorded in Table 1. The amount of carbon, hydrogen and nitrogen of the ligand calculated 
theoretically correspond to a large extent with the experimental result. Because ion spray mass spectrometer was 
used, the mass of NBS2ABT was observed as 358 m/z, the excess mass of 23 m/z was due to sodium ion present 
in the mass spectrometer chamber. 
 
5 Electronic Spectra 
Two bands were observed for the ligand. They are due to π→π* and n→ π* transitions.  
Three bands were observed for Ni(II) complex of NBS2ABT, and the transitions are assigned as follows;  
ν1 =
3T2(F)←3A2 (F) 
ν2 =
3T1(F)←3A2 (F) 
Chemistry and Materials Research                                                                                                                                                    www.iiste.org 
ISSN 2224- 3224 (Print) ISSN 2225- 0956 (Online) 
Vol.6 No.3, 2014 
 
121 
ν3= 
3T1(P)←3A2 (F) transitions. 
Three bands were observed for the Mn(II) complex synthesized, the transitions are assigned:  
ν1 =
  2T1g (H) ← 2A1g 
 
ν2= 
2Eg (H) ← 2Alg transitions of octahedral geometry. 
In a cubic field, three spin-allowed transitions are anticipated because of the splitting of the free- ion ground 4F 
term and the accompanying 4P term. Of course it is essentially a 2-electron transition from t2g5 eg2 to t2g3 eg4. 
Three bands were observed for the Cobalt complex, they are assigned:   
ν1 =
 2T2g(H)← 2T1g(H) 
ν2 =
2A2g(H)←2T1g(H)                                                                                                                                      ν3= 
LMCT transitions. 
Three bands were observed for the Zn(II) complex synthesized, they are probably due to Metal-Ligand Charge 
Transfer (MLCT) transition. We deduced a tetrahedral geometry for the Zn(II) complex. 
Two bands were observed for the Cu(I) complex of the ligand synthesized. Based on the fact that the Cu(II) 
complex was reduced to Cu(I) in this synthesis, there are no d←d transitions15. With this fact, coupled with the 
colour of the complex, we presumed that the bands observed are as a result of charge transfer transitions. We 
therefore proposed tetrahedral geometry for the copper complex synthesized.                                                                                                                                                                                
6 IR Spectra of the NBS2ABT and of its complexes  
The broad peaks observed at the range of 3362-3450 cm-1 in the compounds were assigned to N-H stretching 
vibration for the ligand NBS2ABT,  its Ni(I) Mn(II), Co(II), Zn(II) and Cu(I) complexes respectively. We also 
observed that N-H was involved in the coordination because of the marked difference in the value of the ligand 
compared with the complexes. Two peaks each observed between 2734 cm-1 and 2954 cm-1 for the compounds 
were assigned to   C-H stretching vibrations. Strong peaks observed at the range of 1601-1655 cm-1 in the ligand 
and the complexes were assigned to C=C stretching vibration of the aromatic ring. In this region there was a 
reduction in the stretching frequency of the ligand up to >45 cm-1 compared to the complexes. Thus an indication 
of coordination via the C=C bond. Two strong peaks each between 1461–1545 cm-1 in all the compounds were 
assigned to C=N stretching vibration of benzothiazole ring. Strong peaks between 1310–1380cm-1 in all the 
compounds were assigned to SO2 stretching vibration. The peaks at the range 1217-1275cm-1 were assigned the 
NO2 stretching vibration for the ligand and the complexes. However, strong peaks between 836–958 cm-1 in all 
the compounds were assigned C-H bending vibration of substituted benzene ring. Weak to strong peaks between 
581–685 cm-1 in all the compounds were assigned to C-S-C stretching vibration of thiazole ring. The strong 
peaks observed for the metal complexes between 325–392 cm-1 were assigned M–N, M– (C=C) and M–Cl 
stretching vibrations.  
 
7 1H and 13C NMR Spectral Data 
The peaks at 9.62 ppm (1H, s) in NBS2ABT, 13.43 ppm (1H, s) in Zn(II)NBS2ABT, and 13.56 ppm (1H, s) in 
Cu(I)NBS2ABT are assigned to N-H protons. The peaks at 7.51 ppm (4H, m) in NBS2ABT, 7.41 ppm (4H, m) 
in Zn(II)NBS2ABT, and 7.44 ppm (4H, d) in Cu(I)NBS2ABT are assigned to phenyl protons. The peaks at 8.12 
ppm (4H, m) in NBS2ABT, 7.85 ppm (2H, d) and 7.93 ppm (2H, d) in Zn(II)NBS2ABT, and 8.15 ppm (2H, d) 
in Cu(I)NBS2ABT are assigned to benzothiazole protons. The singlet peaks observed at 3.36 ppm, 2.89 ppm and 
2.50 ppm in Zn(II)NBS2ABT, and between 3.37 ppm- 2.50 ppm in Cu(I)NBS2ABT are due to metal ions 
contribution to the spectra in the complexes. The complexes, Ni(I)NBS2ABT, Mn(II)NBS2ABT and 
Co(II)NBS2ABT are paramagnetic and as such the spectra were not included since they made little or no sense. 
Peaks at 168.4 ppm in the ligand, and at the range of 170.1-130.0 ppm in the metal complexes are assigned 
benzothiazole ring carbons. Peaks at the range of 113.1-136.8 ppm in the ligand and its metal complexes are 
assigned phenyl ring carbon.  
 
8 Magnetic Properties of the Complexes 
The result of the magnetic properties of the complexes is shown in Table 1. It was generally observed that the 
metal complexes were of low spin. This is an indication that the ligand is a strong field and thus was able to 
cause pairing of the electrons. As expected the zinc complex investigated gave very small effective magnetic 
moment, µeff (1.53 BM). Therefore the zinc complex is diamagnetic, and has sp3 hybridized geometry, thus 
tetrahedral structure. Ni(I)NBS2ABT complex showed effective magnetic moment of 1.84 BM. This showed 
high spin configuration and corresponds to an unpaired electron, indicating paramagnetism. We however 
concluded that there were some interactions between the ligand, NBS2ABT and the metal in the complex. We 
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presumed that the ligand, NBS2ABT may have reduced the Ni2+ to Ni+ ion. We therefore proposed sp3 
hybridized geometry for the complex. Co(II)NBS2ABT showed effective magnetic moment of 2.11 BM. This is 
an indication of low spin paramagnetism corresponding to one unpaired electron. We proposed sp3d2 
hybridization of octahedral geometry. The manganese complex investigated showed effective magnetic moment 
of 3.29 BM. This is indication of low spin paramagnetism corresponding to an unpaired electron. We proposed 
d2sp3 hybridization of octahedral geometry. The Cu(I) complex investigated showed diamagnetism, indicating no 
unpaired electrons in the metal d-orbitals. Since there is no possibility of electron pairing in the d-orbitals, we are 
presuming that the ligand may have induced reduction of the Cu2+ to Cu+. This is also confirmed by the light 
brown colour of the complex formed. We also proposed sp3 hybridization of tetrahedral geometry for all the 
Cu(I) complex investigated.  
 
9 Antimicrobial activity of the ligand and of its metal complexes 
The antimicrobial activities of the ligand and of its metal complexes are recorded in Tables 2 and 3. 
Table 2 showed the activities against multi-resistant bacterial strains isolated under clinical conditions. Two 
strains each of E. Coli (E.Coli strain 1 and E. Coli strain 15), and Proteus species (Proteus spp strains 25 and 
Proteus spp strains 26), P. aeroginosa strains 34 and multi-resistant S. aureus (SR) strain, all isolated from dogs 
at clinical conditions were used.  
Table 3 showed activities of the compounds against Typed Strains (ATCC Cultures) microorganisms. The 
bacteria cultures used are P. aeruginosa (ATCC 27853), E. coli (ATCC 25922) and S. aureus (ATCC 25923). 
The fungi, C. krusei (ATCC 6258) and C. albicans (ATCC 90028) were also used.  
All the compound synthesized showed activity against at least one of the tested microbes. We adjudged that as in 
the case of the activity against the multi-resistant bacteria, Zn(II)NBS2ABT showed the highest of activity in 
that it was active against all the pathogens of the typed strains used-both the bacteria and fungi with MIC of 
0.625 mg/ml and IZD of 10 mm against S. aureus (ATCC 25923) except E. coli (ATCC 25922) and C. albicans 
(ATCC 90028). This followed by the cobalt complex. All the compounds showed activity against S. aureus 
(ATCC 25923). None of the compounds were active against P. aeruginosa (ATCC 27853). All the compounds 
were active against C. krusei (ATCC 6258) except the cobalt complex. Only the ligand and its nickel complex 
were active against C. albicans (ATCC 90028) with MIC of 10 mg/ml and IZD of 10 mm. All the compounds 
synthesized did not show detectable activity against E. coli (ATCC 25922). 
The result indicates that the zinc complex showed the highest activity against the pathogens. All the compounds 
except the cobalt complex were active against C. krusei (ATCC 6258). Fluconazole is primarily fungistatic but 
can be fungicidal against certain organisms in dose-dependent manner. Fluconazole was only active against the 
typed strain C. albicans (ATCC 90028) but not against C. krusei tested strains. This was confirmed from 
literature(16). We can conclude that the compounds showed some degree of activity against the tested 
microorganisms which to a large extent can be compared with the standard drugs used. Since the standard 
antifungal drug used did not show activity against the C. krusei (ATCC 6258), we can say that the ligand, 
NBS2ABT and its complexes except the cobalt complex were more active that the fluconazole.  
 
10 Lethal Concentration (LC50) and Effective Concentration (EC50) 
The result of the Cytotoxic tests viz; Lethal Concentration (LC50) and Effective Concentration (EC50) are 
recorded in Table 4. 
The result showed that all the synthesized compounds showed high levels of bioactivity against 48 h-nauplii. 
Zn(II)NBS2ABT showed the highest bioactivity (5.00±0.86 ppm) with EC50 of 0.5 ppm while Mn(II)NBS2ABT 
showed the lowest bioactivity (618.90±30.8 ppm) with EC50 of 61.9 ppm. Comparing the compounds, the level 
of bioactivity is in the order Mn(II)NBS2ABT > NBS2ABT > Ni(I)NBS2ABT > Co(II)NBS2ABT > 
Cu(I)NBS2ABT > Zn(II)NBS2ABT. 
The results of Brine Shrimps Lethality Test (BSLT) established that the ligand and the complexes are very potent 
bioactive compounds. EC50 value for general bioactivity is approximately one tenth of the value is the LC50 in 
BSLT. The surviving nauphii were dull and inactive, which may be a sign of Central Nervous System (CNS) 
depression. 
 
11 CONCLUSION  
N-(benzothiazol-2-yl)-2-nitrobenzenesulphonamide and its metal complexes were synthesized. The compounds 
were characterized using magnetic susceptibility measurements, mass spectrometry, elemental microanalysis, 
UV/VIS spectrophotometry, infra red, proton and 13C nmr spectroscopies.  The spectral analyses confirmed the 
structures of the compounds synthesized. The antimicrobial tests of the ligands and its metal complexes were 
carried out on both multi-resistant bacterial and fungal strains isolated under clinical conditions and cultured 
species using agar-well diffusion method. The tests were both in vitro and in vivo. The antimicrobial activities of 
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the compounds were compared with those of ciprofloxacin and trimethoprim-sulphamethoxazole as antibacterial 
agents and Fluconazole as an antifungal drug. All the compounds showed varying activities against the cultured 
typed bacteria and fungi used. However, they were less active than the standard bacterial drugs used, and since 
the standard antifungal drug (fluconazole) used did not show activity against the Candida krusei (ATCC 6258), 
we can conclude that the ligand, NBS2ABT and its complexes except the cobalt complex were more active that 
the fluconazole, and can be recommended for preclinical screening. The Lethal Concentrations (LC50) were 
within the permissible concentrations. 
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Table 1: Physical properties of the ligand, NBS2ABT and of its metal Complexes, the Magnetic Properties of the 
Complexes, and Elemental microanalysis of the ligand 
 
S/n 
SAMPLES Melting 
Point (oC) 
Colour Texture 
 
 
Mw µeff 
(BM) 
No. of 
Electrons 
Properties 
1 NBS2ABT 210-212 Yellow Powdery 358.00
 
- - - 
2 Ni(I)NBS2ABT 193-195 Light 
yellow 
Needle-
like 
764.19 1.84 1 Paramagnetic 
3 Mn(II)NBS2ABT 187-189 Yellow  Needle-
like 
795.94 3.29 1 Paramagnetic 
4 Co(II)NBS2ABT 185-187 Light blue Needle-
like 
799.93 2.11 1 Paramagnetic 
5 Zn(II)NBS2ABT 177-179 Light 
yellow 
Crystalline 735.39 1.53 0 Diamagnetic 
6 Cu(I)NBS2ABT 159-161  Light 
brown 
Powdery 769.05 0.71 0 Diamagnetic 
                                                        Elemental microanalysis of the ligand, NBS2ABT 
 %C %H %N 
Calc. Found Calc. Found Calc. Found 
NBS2ABT 46.58 44.98 2.69 3.07 12.54 12.66 
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Table 4: Lethal Concentration (LC50) and Effective Concentration  
               (EC50) Results in ppm (Cytotoxic test) 
 S/N SAMPLES LC50 (ppm) EC50 (ppm) 
1 NBS2ABT 401.90±18.0 40.2 
2 Ni(I)NBS2ABT 333.60±21.0 33.4 
3 Mn(II)NBS2ABT 618.90±30.8 61.9 
4 Co(II)NBS2ABT 164.56±40.18 16.5 
5 Zn(II)NBS2ABT 5.00±0.86 0.5 
6 Cu(I)NBS2ABT 19.66±2.44 2.0 
 
 
 
 
 
 
 
 
